← Back to Clinical Trials
Recruiting NCT07143110

LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada

Trial Parameters

Condition Lung Neoplasms
Sponsor AstraZeneca
Study Type OBSERVATIONAL
Phase N/A
Enrollment 60,000
Sex ALL
Min Age 18 Years
Max Age 130 Years
Start Date 2025-08-20
Completion 2027-09-30

Brief Summary

LUNG-ROLL is a retrospective cohort study that will describe the contemporary treatment patterns, prevalence and incidence, patient demographic and clinical characteristics, clinical outcomes, and healthcare resource use/costs for patients with lung cancer in Canada (specifically, Alberta and Ontario) using administrative data.

Eligibility Criteria

Inclusion Criteria: * Patients with lung cancer between January 1, 2018 and end of the Selection Period. * Patient is 18 years of age or older on diagnosis date. * Patient has at least 12 months of health insurance coverage prior to the diagnosis date. Exclusion Criteria: * Diagnosed with any other cancer in the 5-year period prior to January 1, 2018. * Diagnosed with any other cancer concurrently (i.e., on the same date) as lung cancer diagnosis. * Invalid or incomplete records for key variables (e.g., missing year of diagnosis, missing cancer type). * Non-Ontario or non-Alberta resident on diagnosis date.

Related Trials